Completed OBSERVATIONAL NCT01523665

Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System

Evaluation of Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System

Sponsor: B. Braun Melsungen AG

Updated 7 times since 2017 Last updated: Nov 26, 2013 Started: Oct 31, 2011 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Intensive Care Patients, this trial is completed. The trial is conducted by B. Braun Melsungen AG and has accumulated 7 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

B. Braun Melsungen AG

Data source: B. Braun Melsungen AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Augsburg, Germany , Bury Saint Edmonds, United Kingdom , Copenhagen, Denmark , Hradec Králové, Czechia , Jönköping, Sweden , Legnano, Italy , Leipzig, Germany , Madrid, Spain , Pilsen, Czechia , Prague, Czechia and 7 more locations